Literature DB >> 23034528

The association of early transfusion with acute lung injury in patients with severe injury.

Daniel N Holena1, Giora Netzer, Russell Localio, Robert J Gallop, Scarlett L Bellamy, Nuala J Meyer, Michael G S Shashaty, Paul N Lanken, Sandra Kaplan, Patrick M Reilly, Jason D Christie.   

Abstract

BACKGROUND: Packed red blood cell (PRBC) transfusion is associated with acute lung injury (ALI) development after trauma, but this risk may not be constant through time after trauma. We hypothesized that the relationship between PRBC delivery and ALI risk varies through time after injury.
METHODS: Data were collected prospectively from 1999 to 2006. Inclusion criteria include the following: older than 13 years, surgical intensive care unit admission, and Injury Severity Score of 16 or greater. Exclusion criteria included discharge/death within 24 hours of admission. Patients were followed up prospectively for ALI development for 5 days after trauma. Discrete time models were fit to test the association of timing of PRBC delivery with the development of ALI while controlling for patient demographics, resuscitation variables, Injury Severity Score, and Acute Physiology and Chronic Health Evaluation III scores.
RESULTS: At total of 602 patients were included. Median age was 33 years, 77% were male, and 50% were African American. Using a discrete time-survival model, the relation between transfusion and ALI development was found to vary by transfusion time window (p < 0.0001). The major effect of PRBC delivery on ALI risk occurred in the first 24 hours after trauma; this finding persisted in multivariable modeling (adjusted odds ratio, 1.07 per unit; 95% confidence interval, 1.02-1.11, p < 0.001). Cumulative incidence of ALI approached 50% in patients receiving 6 U of PRBC or more in the first 24 hours.
CONCLUSION: The association between PRBC transfusion and ALI development in patients with trauma is time dependent, with PRBC delivery in the first 24 hours after injury driving the overall relation. Each PRBC unit during this period increases odds of subsequent ALI development by 7%. LEVEL OF EVIDENCE: Prognostic/epidemiologic study, level II.

Entities:  

Mesh:

Year:  2012        PMID: 23034528      PMCID: PMC3541013          DOI: 10.1097/TA.0b013e318256de38

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  21 in total

Review 1.  Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel.

Authors:  Steven Kleinman; Tim Caulfield; Penny Chan; Robertson Davenport; Janice McFarland; Susan McPhedran; Maureen Meade; Douglas Morrison; Thomas Pinsent; Pierre Robillard; Peter Slinger
Journal:  Transfusion       Date:  2004-12       Impact factor: 3.157

2.  The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma.

Authors:  Howard Silverboard; Imo Aisiku; Greg S Martin; Monica Adams; Grace Rozycki; Marc Moss
Journal:  J Trauma       Date:  2005-09

3.  Blood transfusion is associated with infection and increased resource utilization in combat casualties.

Authors:  James R Dunne; Mark S Riddle; Janine Danko; Rich Hayden; Kyle Petersen
Journal:  Am Surg       Date:  2006-07       Impact factor: 0.688

4.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Authors:  P C Hébert; G Wells; M A Blajchman; J Marshall; C Martin; G Pagliarello; M Tweeddale; I Schweitzer; E Yetisir
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

6.  Blood transfusion. An independent risk factor for postinjury multiple organ failure.

Authors:  F A Moore; E E Moore; A Sauaia
Journal:  Arch Surg       Date:  1997-06

Review 7.  Anemia, allogenic blood transfusion, and immunomodulation in the critically ill.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

8.  Transfusions result in pulmonary morbidity and death after a moderate degree of injury.

Authors:  Martin A Croce; Elizabeth A Tolley; Jeffrey A Claridge; Timothy C Fabian
Journal:  J Trauma       Date:  2005-07

9.  Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients.

Authors:  Herb A Phelan; Jason L Sperry; Randall S Friese
Journal:  J Surg Res       Date:  2006-12-11       Impact factor: 2.192

Review 10.  The pathogenesis of transfusion-related acute lung injury (TRALI).

Authors:  Jürgen Bux; Ulrich J H Sachs
Journal:  Br J Haematol       Date:  2007-03       Impact factor: 6.998

View more
  9 in total

1.  ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis.

Authors:  John P Reilly; Nuala J Meyer; Michael G S Shashaty; Rui Feng; Paul N Lanken; Robert Gallop; Sandra Kaplan; Maximilian Herlim; Nathaniel L Oz; Isabel Hiciano; Ana Campbell; Daniel N Holena; Muredach P Reilly; Jason D Christie
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Predictors of postinjury acute respiratory distress syndrome: Lung injury persists in the era of hemostatic resuscitation.

Authors:  Lucy Z Kornblith; Anamaria J Robles; Amanda S Conroy; Brittney J Redick; Benjamin M Howard; Carolyn M Hendrickson; Sara Moore; Mary F Nelson; Farzad Moazed; Rachael A Callcut; Carolyn S Calfee; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2019-08       Impact factor: 3.313

3.  The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time.

Authors:  Lisa K Vande Vusse; Ellen Caldwell; Edward Tran; Laurie Hogl; Steven Dinwiddie; José A López; Ronald V Maier; Timothy R Watkins
Journal:  Ann Am Thorac Soc       Date:  2015-09

4.  Red blood cells induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation.

Authors:  Danielle Y Qing; David Conegliano; Michael G S Shashaty; Jeongyun Seo; John P Reilly; G Scott Worthen; Dongeun Huh; Nuala J Meyer; Nilam S Mangalmurti
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

5.  The acute respiratory distress syndrome following isolated severe traumatic brain injury.

Authors:  Carolyn M Hendrickson; Benjamin M Howard; Lucy Z Kornblith; Amanda S Conroy; Mary F Nelson; Hanjing Zhuo; Kathleen D Liu; Geoffrey T Manley; Michael A Matthay; Carolyn S Calfee; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2016-06       Impact factor: 3.313

6.  Supernatants and lipids from stored red blood cells activate pulmonary microvascular endothelium through the BLT2 receptor and protein kinase C activation.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; F Bernadette West; Nathan J D McLaughlin; David J Elzi; Kelly England; Jason Bjornsen; Susan A Kuldanek; Anirban Banerjee
Journal:  Transfusion       Date:  2017-09-06       Impact factor: 3.157

7.  Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality.

Authors:  Nicola Curry; Amber Raja; James Beavis; Simon Stanworth; Paul Harrison
Journal:  J Extracell Vesicles       Date:  2014-10-31

8.  A Derivation and Validation Study of an Early Blood Transfusion Needs Score for Severe Trauma Patients.

Authors:  Hao Wang; Johnbosco Umejiego; Richard D Robinson; Chet D Schrader; JoAnna Leuck; Michael Barra; Stefan Buca; Andrew Shedd; Andrew Bui; Nestor R Zenarosa
Journal:  J Clin Med Res       Date:  2016-07-01

9.  Crosstalk signaling between alveoli and capillaries.

Authors:  Rebecca F Hough; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  Pulm Circ       Date:  2018-06-05       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.